TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$15 Million

Ekso Bionics

Follow-on Offering

Sole Bookrunner, August 2016

Confidentially Marketed Public Offering

Ekso Bionics Holdings designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Asia. The company operates through Engineering Services and Medical segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, stroke, and other lower limb paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a collaborative partnership with Lockheed Martin Corporation to develop products for military applications, as well as a license agreement with OttoBock Healthcare Products Gmbh.